EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Persistent excess mortality in post-pandemic Japan: current evidence, methodological limitations, and future directions

Hiroshi Kusunoki, Ryota Sakai, Yumi Watanabe, Hideki Kakeya

Frontiers in Public Health · 23.06.2026 · 14

DOI: 10.3389/fpubh.2026.1878166 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Public Health, online erschienen am 23.06.2026. Verfasst von Hiroshi Kusunoki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Osaka Dental University, Hirakata, Japan. Hauptthemen laut MEDLINE: COVID-19, Mortality. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than six years after the emergence of COVID-19, Japan continues to experience persistently elevated excess mortality despite entering a post-pandemic phase. Excess mortality, defined as the difference between observed and expected deaths, reflects both direct and indirect effects of the pandemic, including healthcare disruption, delayed care, and broader social changes. In Japan, mortality decreased slightly in 2020 but increased markedly from 2022 onward, with annual excess deaths approaching 100,000, despite widespread vaccination and the predominance of the less virulent Omicron variant. Multiple factors may underlie this sustained increase, including population aging, changes in healthcare access, delayed diagnosis and treatment, regional disparities, and psychosocial stress. Some ecological and observational studies have reported a statistical association between repeated COVID-19 booster vaccination and excess mortality in Japan; however, these findings do not establish causality, and a causal relationship cannot currently be concluded. Against this background, this narrative review examines persistent excess mortality in Japan, uses the literature on repeated booster vaccination as an illustrative example to highlight methodological limitations, and discusses the need for nationwide, linked individual-level data infrastructure and appropriate analytical frameworks for more robust future evaluations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MortalityJapanHumansCOVID-19 VaccinesPandemicsSARS-CoV-2Immunization, Secondary

Stichwörter der Autor:innen

COVID-19all-cause mortalitybooster vaccinationexcess mortalityhealthy vaccinee biasindividual-level data infrastructuremethodological limitations

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Internal Medicine, Osaka Dental University, Hirakata, Japan.
  • Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
  • Division of Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Institute of Systems and Information Engineering, University of Tsukuba, Tsukuba, Japan.
  • Transdisciplinary Review Association, Moriya, Japan.

Zitieren

APA

Kusunoki, H., Sakai, R., Watanabe, Y., & Kakeya, H. (2026). Persistent excess mortality in post-pandemic Japan: current evidence, methodological limitations, and future directions. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1878166

Vancouver

Kusunoki H, Sakai R, Watanabe Y, Kakeya H. Persistent excess mortality in post-pandemic Japan: current evidence, methodological limitations, and future directions. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1878166

BibTeX
@article{Kusunoki2026,
  author = {Kusunoki, Hiroshi and Sakai, Ryota and Watanabe, Yumi and Kakeya, Hideki},
  title = {Persistent excess mortality in post-pandemic Japan: current evidence, methodological limitations, and future directions},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1878166}
}
Kostenlos starten →